mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.02 |